Generated by AI
Calithera Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule compounds, primarily in the field of tumor biology. Its primary function involves discovering and advancing therapeutic candidates that can potentially address various cancer-related challenges. The company operates within the biotechnology sector, specifically targeting precision oncology. Although it has transitioned into a plan of liquidation, historically, Calithera Biosciences Inc. contributed to advancements in cancer treatment through innovative small molecule therapies. Headquartered in South San Francisco, California, the company was founded in 2010 and played a role in shaping the landscape of cancer research.
Website343 Oyster Point Boulevard
South San Francisco, CA, 94080
United States
Summary of Mar 10's posts. Generated by AI.
Summary of Feb 21's posts. Generated by AI.
Summary of Jan 10's posts. Generated by AI.
Investors talking about CALA also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.